Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2643

1.

Glutamate-mediated excitotoxicity in schizophrenia: A review.

Plitman E, Nakajima S, de la Fuente-Sandoval C, Gerretsen P, Chakravarty MM, Kobylianskii J, Chung JK, Caravaggio F, Iwata Y, Remington G, Graff-Guerrero A.

Eur Neuropsychopharmacol. 2014 Aug 1. pii: S0924-977X(14)00215-6. doi: 10.1016/j.euroneuro.2014.07.015. [Epub ahead of print] Review.

PMID:
25159198
[PubMed - as supplied by publisher]
2.

Bioanalysis of (1R,4R,5S,6R)-4-amino-2-oxabicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY379268) in rat plasma using derivatization liquid chromatography/mass spectrometry.

Benitex Y, Luan FN, Shields E, McNaney CA, Morgan DG, Olah TV, Drexler DM.

Bioanalysis. 2014 Jul;6(14):1901-1905.

PMID:
25158962
[PubMed - as supplied by publisher]
3.

Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: Effect of antidepressant treatment.

Muguruza C, Miranda-Azpiazu P, Díez-Alarcia R, Morentin B, González-Maeso J, Callado LF, Meana JJ.

Neuropharmacology. 2014 Aug 20. pii: S0028-3908(14)00292-5. doi: 10.1016/j.neuropharm.2014.08.009. [Epub ahead of print]

PMID:
25150943
[PubMed - as supplied by publisher]
4.

Understanding the role α7 nicotinic receptors play in dopamine efflux in nucleus accumbens.

Maex R, Grinevich VP, Grinevich V, Budygin EA, Bencherif M, Gutkin B.

ACS Chem Neurosci. 2014 Aug 22. [Epub ahead of print]

PMID:
25147933
[PubMed - as supplied by publisher]
5.

Reduced gene expression levels of Munc13-1 and additional components of the presynaptic exocytosis machinery upon conditional targeting of Vglut2 in the adolescent mouse.

Rajagopalan A, Schweizer N, Nordenankar K, Nilufar Jahan S, Emilsson L, Wallén-Mackenzie A.

Synapse. 2014 Aug 19. doi: 10.1002/syn.21776. [Epub ahead of print]

PMID:
25139798
[PubMed - as supplied by publisher]
6.

Selective Activation of M4 Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents.

Bubser M, Bridges TM, Dencker D, Gould RW, Grannan M, Noetzel MJ, Lamsal A, Niswender CM, Daniels JS, Poslusney MS, Melancon BJ, Tarr JC, Byers FW, Wess J, Duggan ME, Dunlop J, Wood MW, Brandon NJ, Wood MR, Lindsley CW, Conn PJ, Jones CK.

ACS Chem Neurosci. 2014 Aug 19. [Epub ahead of print]

PMID:
25137629
[PubMed - as supplied by publisher]
7.

Chemical modulation of mutant mGlu1 receptors derived from deleterious GRM1 mutations found in schizophrenics.

Cho HP, Garcia-Barrantes PM, Brogan JT, Hopkins CR, Niswender CM, Rodriguez AL, Venable D, Morrsion RD, Bubser M, Daniels JS, Jones CK, Conn PJ, Lindsley CW.

ACS Chem Biol. 2014 Aug 19. [Epub ahead of print]

PMID:
25137254
[PubMed - as supplied by publisher]
8.

Mutant disrupted-in-schizophrenia 1 in astrocytes: Focus on glutamate metabolism.

Abazyan S, Yang EJ, Abazyan B, Xia M, Yang C, Rojas C, Slusher B, Sattler R, Pletnikov M.

J Neurosci Res. 2014 Aug 8. doi: 10.1002/jnr.23459. [Epub ahead of print]

PMID:
25131692
[PubMed - as supplied by publisher]
9.

Downstream effects of striatal-enriched protein tyrosine phosphatase reduction on RNA expression in vivo and in vitro.

Reinhart VL, Nguyen T, Gerwien R Jr, Kuhn M, Yates PD, Lanz TA.

Neuroscience. 2014 Aug 15. pii: S0306-4522(14)00642-3. doi: 10.1016/j.neuroscience.2014.08.002. [Epub ahead of print]

PMID:
25130559
[PubMed - as supplied by publisher]
10.

[Neurobiology of schizophrenia : New findings from the structure to the molecules.]

Schmitt A, Malchow B, Keeser D, Falkai P, Hasan A.

Nervenarzt. 2014 Aug 17. [Epub ahead of print] German.

PMID:
25123366
[PubMed - as supplied by publisher]
11.

Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission.

Snyder GL, Vanover KE, Zhu H, Miller DB, O'Callaghan JP, Tomesch J, Li P, Zhang Q, Krishnan V, Hendrick JP, Nestler EJ, Davis RE, Wennogle LP, Mates S.

Psychopharmacology (Berl). 2014 Aug 15. [Epub ahead of print]

PMID:
25120104
[PubMed - as supplied by publisher]
12.

Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study.

Durrenberger PF, Fernando FS, Kashefi SN, Bonnert TP, Seilhean D, Nait-Oumesmar B, Schmitt A, Gebicke-Haerter PJ, Falkai P, Grünblatt E, Palkovits M, Arzberger T, Kretzschmar H, Dexter DT, Reynolds R.

J Neural Transm. 2014 Aug 13. [Epub ahead of print]

PMID:
25119539
[PubMed - as supplied by publisher]
13.

Increased visual gamma power in schizoaffective bipolar disorder.

Brealy JA, Shaw A, Richardson H, Singh KD, Muthukumaraswamy SD, Keedwell PA.

Psychol Med. 2014 Aug 13:1-12. [Epub ahead of print]

PMID:
25115407
[PubMed - as supplied by publisher]
14.

Activity-dependent alterations in the sensitivity to BDNF-TrkB signaling may promote excessive dendritic arborization and spinogenesis in fragile X syndrome in order to compensate for compromised postsynaptic activity.

Kim SW, Cho KJ.

Med Hypotheses. 2014 Jul 18. pii: S0306-9877(14)00262-X. doi: 10.1016/j.mehy.2014.07.007. [Epub ahead of print]

PMID:
25113167
[PubMed - as supplied by publisher]
15.

[The glutamate hypothesis of schizophrenia].

Hasan A, Malchow B, Falkai P, Schmitt A.

Fortschr Neurol Psychiatr. 2014 Aug;82(8):447-56. doi: 10.1055/s-0034-1366571. Epub 2014 Aug 8. German.

PMID:
25105431
[PubMed - in process]
16.

Behavioral characterization of striatal-enriched protein tyrosine phosphatase (STEP) knockout mice.

Rizzo SJ, Lotarski SM, Stolyar P, McNally T, Arturi C, Roos M, Finley JE, Reinhart V, Lanz TA.

Genes Brain Behav. 2014 Aug 8. doi: 10.1111/gbb.12169. [Epub ahead of print]

PMID:
25103464
[PubMed - as supplied by publisher]
17.

Dysregulated nitric oxide signaling as a candidate mechanism of fragile X syndrome and other neuropsychiatric disorders.

Colvin SM, Kwan KY.

Front Genet. 2014 Jul 22;5:239. doi: 10.3389/fgene.2014.00239. eCollection 2014. Review.

PMID:
25101118
[PubMed]
Free PMC Article
18.

The neurobiology of methamphetamine induced psychosis.

Hsieh JH, Stein DJ, Howells FM.

Front Hum Neurosci. 2014 Jul 22;8:537. doi: 10.3389/fnhum.2014.00537. eCollection 2014. Review.

PMID:
25100979
[PubMed]
Free PMC Article
19.

Reduction of brain kynurenic Acid improves cognitive function.

Kozak R, Campbell BM, Strick CA, Horner W, Hoffmann WE, Kiss T, Chapin DS, McGinnis D, Abbott AL, Roberts BM, Fonseca K, Guanowsky V, Young DA, Seymour PA, Dounay A, Hajos M, Williams GV, Castner SA.

J Neurosci. 2014 Aug 6;34(32):10592-602. doi: 10.1523/JNEUROSCI.1107-14.2014.

PMID:
25100593
[PubMed - in process]
20.

Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia.

Bishop JR, Reilly JL, Harris MS, Patel SR, Kittles R, Badner JA, Prasad KM, Nimgaonkar VL, Keshavan MS, Sweeney JA.

Psychopharmacology (Berl). 2014 Aug 7. [Epub ahead of print]

PMID:
25096017
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk